The Roles of Gut Microbiome in UTI Susceptible Women
Investigate the Roles of Gut Microbiome in the Differential Responses of UTI Susceptible Women to Cranberry Juice Intake
3 other identifiers
interventional
160
1 country
1
Brief Summary
Clinical trials on cranberry juice and UTI prevention yielded both positive and negative results for unknown reason. Gut microbiome in women affect the absorption and metabolism of cranberry bioactives. The variation of gut microbiome is a probable mechanism for metabolic polymorphisms and disparity in UTI prevention in women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Oct 2021
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2021
CompletedFirst Posted
Study publicly available on registry
October 1, 2021
CompletedStudy Start
First participant enrolled
October 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
September 5, 2025
September 1, 2025
4.8 years
September 29, 2021
September 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the unrinary anti-adhesion activity of UTI susceptible women
Compare the statistical differences between the changes from baseline in the an-adhesion activity against uropathogenic E. coli in UTI-susceptible women after consuming the cranberry juice for 3 weeks versus after consuming the placebo juice for 3 weeks. Anti-adhesion activity in urine will be measured using a fluorescence-based microplate method. The anti-adhesion activities of urines will be expressed by its equivalence to myricetin level. The unit for urine anti-adhesion activities is µg myricetin/mg creatinine.
Baseline up to 21 days of each intervention
Secondary Outcomes (2)
Determine the compositional differences of gut microbiome in responders and non-responders after the cranberry juice intake
Baseline up to 21 days of each intervention
Identify anti-adhesion urinary biomarkers in responders versus non-responders after the cranberry juice intake
Baseline upt to 21 days of each intervention
Study Arms (2)
Cranberry juice consumption
EXPERIMENTALParticipants deemed as responders and non-responders will be given 20-30 oz (590-885 mL) of cranberry juice daily for 3 weeks.
Apple juice consumption
EXPERIMENTALParticipants deemed as responders and non-responders will be given 20-30 oz (590-885 mL) apple juice with matching sugar and calories daily for 3 weeks.
Interventions
The responders and non-responders will drink 20-30 oz of (590-885 mL) 27% cranberry juice daily for 3 weeks.
The participants will drink apple juice with matching sugar content and calories for 3 weeks
Eligibility Criteria
You may qualify if:
- Healthy women participants;
- BMI 18.5-29.9 kg/m2;
- At least 110 pounds in weight
You may not qualify if:
- BMI≥ 30 kg/m2;
- Pregnancy and breast-feeding;
- Smoking, frequent alcohol use;
- History of any clinically important disorder that may interfere with interpretation of the results;
- Intake of medication that might influence the outcome of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32611, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Liwei Gu, PhD
University of Florida
- STUDY DIRECTOR
Gary P Wang, PhD
University of Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2021
First Posted
October 1, 2021
Study Start
October 18, 2021
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
September 5, 2025
Record last verified: 2025-09